98%
921
2 minutes
20
Background: Senile stroke patients with frailty are more likely to have adverse clinical outcomes such as falls, disability and re-admission. Severe frailty may even lead to death. Therefore, early identification of frailty and targeted intervention measures will help to reduce or delay the occurrence and development of frailty in senile stroke patients and avoid related adverse outcomes.
Methods: From September 2022 to March 2023, 415 senile stroke patients from a hospital in Liaoning Province were selected by convenient sampling method. Collect data through questionnaire survey, screen the independent influencing factors of patients' frailty, use R software to draw the nomogram of multivariate logistic regression model, and verify the model according to the area under the ROC curve (AUC), calibration curve and clinical decision curve (DCA).
Results: A total of 415 participants were collected, and the incidence of frailty was 72.5 %. Impaired ADL (OR=5.713, 95 %CI: 1.296-25.194), frequency of incidence(OR=4.694, 95 %CI: 1.505-14.64), anxiety (OR=17.398, 95 %CI: 4.251-71.214), depression(OR=5.578, 95 %CI: 1.659-18.752) and abnormal nutritional status (OR=6.335, 95 %CI: 1.69-23.74) were independent risk factors for senile stroke patients, and social support (OR=0.826, 95 %CI: 0.773-0.882) was protective factor. AUC is 0.957 (95 %CI: 0.967-0.989). The calibration curve shows that the calibration curve fits the ideal curve. The clinical decision curve shows that this model has good clinical practicability.
Conclusions: The frail risk prediction model of senile stroke patients established in this study has a good prediction effect, which is conducive to early detection of frail high-risk groups, so as to guide medical personnel to take targeted treatment measures to reduce the incidence of frailty.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.gerinurse.2025.103477 | DOI Listing |
Curr Issues Mol Biol
August 2025
Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, China.
Isoliquiritigenin (ISL) is a type of chalcone that widely exists in medicinal plants of the Leguminosae family and exhibits a remarkable anti-ischemic stroke (IS) effect. However, the anti-IS mechanisms of ISL remain to be systematically elucidated. In this study, network pharmacology was used to predict potential targets related to the anti-IS effect of ISL.
View Article and Find Full Text PDFJ Nat Med
September 2025
Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Xihu District, Hangzhou, 310058, China.
Blood-brain barrier (BBB) dysfunction is a well-established pathological phenotype of ischemic stroke, and targeting BBB integrity has emerged as a promising therapeutic strategy. Danshen-Chuanxiong formula (DS-CX), an effective herbal combination against ischemic stroke, has demonstrated regulatory effects on the BBB at various stages of ischemic stroke. However, its specific BBB-protective components and underlying molecular mechanisms remain unclear.
View Article and Find Full Text PDFiScience
August 2025
Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, 1166 Liutai Road, Chengdu 611137, China.
The molecular mechanisms of brain-body interactions in the progression of brain diseases remain unknown. Through integrative analysis of multi-organ proteomic, metabolomic, and transcriptomic data following ischemic stroke, we identified dynamic molecular signatures across organs. The heart exhibited the highest number of differentially expressed proteins (DEPs), followed by spleen and intestine.
View Article and Find Full Text PDFEClinicalMedicine
August 2025
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Background: Atorvastatin and rosuvastatin are the most widely used statins in patients with ischemic stroke or transient ischemic attack (TIA). However, evidence on their effectiveness and safety during actual use is scarce. This study aims to compare the effectiveness and safety of initiating atorvastatin versus rosuvastatin among patients with ischemic stroke or TIA.
View Article and Find Full Text PDFFront Pharmacol
July 2025
First Clinic College, Liaoning University of Traditional Chinese Medicine, Shenyang, China.
Objective: This research sought to demonstrate potential therapeutic strategies for coronary heart disease (CHD) patients with cerebral ischemic stroke (CIS) by rigorously evaluating the efficacy and safety of Chinese Herbal Medicine (CHM) through meta-analysis.
Methods: A broad search approach was applied to obtain pertinent articles from both domestic and international databases, covering publications up to 31 December 2024. Using RevMan software (Version 5.